PET/CT in nononcological lung diseases: current applications and future perspectives
S Capitanio, AJ Nordin, AR Noraini… - European Respiratory …, 2016 - Eur Respiratory Soc
Positron emission tomography (PET) combined with computed tomography (CT) is an
established diagnostic modality that has become an essential imaging tool in oncological …
established diagnostic modality that has become an essential imaging tool in oncological …
Clinical utility of FDG–PET and PET/CT in non-malignant thoracic disorders
There have been several endeavors made to investigate the potential role of 2-deoxy-2-[18
F] fluoro-D-glucose positron emission tomography (FDG-PET)(and tracers) and PET …
F] fluoro-D-glucose positron emission tomography (FDG-PET)(and tracers) and PET …
FDG-PET/CT in lung cancer: an update
The prognosis of lung cancer patients mostly depends on the stage at which the disease is
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
State-of-the-art FDG-PET imaging of lung cancer
MD Gilman, SL Aquino - Seminars in Roentgenology, 2005 - Elsevier
The d-glucose analog 2-(fluorine-18)-fluoro-2-deoxy-d-glucose (FDG) is the most commonly
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …
Value of FDG-PET in the management of non-small cell lung cancer
S Stroobants, J Verschakelen… - European journal of …, 2003 - Elsevier
In the past 5 years, metabolic imaging with positron emission tomography (PET) using 18F-
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
Evaluation of pulmonary lesions with positron emission tomography
MV Knopp, HG Bischoff - Der Radiologe, 1994 - europepmc.org
Positron emission tomography (PET) with fluor-18-labeled deoxyglucose (FDG) enables
metabolically oriented imaging of intrapulmonary lesions. PET is currently not used for the …
metabolically oriented imaging of intrapulmonary lesions. PET is currently not used for the …
Lung cancer and positron emission tomography with fluorodeoxyglucose
EM Marom, JJ Erasmus, EF Patz Jr - Lung Cancer, 2000 - Elsevier
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
JF Vansteenkiste, SG Stroobants - European Respiratory …, 2001 - Eur Respiratory Soc
In the past 5 yrs, positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
Recent and current advances in FDG-PET imaging within the field of clinical oncology in NSCLC: a review of the literature
K Kaseda - Diagnostics, 2020 - mdpi.com
Lung cancer is the leading cause of cancer-related deaths around the world, the most
common type of which is non-small-cell lung cancer (NSCLC). Computed tomography (CT) …
common type of which is non-small-cell lung cancer (NSCLC). Computed tomography (CT) …
Role of positron emission tomography computed tomography in carcinoma lung evaluation
S Padma, SP Sundaram, S George - Journal of Cancer Research …, 2011 - journals.lww.com
Lung cancer has graduated from merely a reportable disease of 1912 to being the most
common cause of cancer death in developed countries in recent years. The annual number …
common cause of cancer death in developed countries in recent years. The annual number …